Area of research
Pediatrics, Perinatology and Child Health · Public Health, Environmental and Occupational Health
Research interest
Research focused on Clinical trial and Agency (philosophy), with related work in Drug development, AMPK, Protein kinase A. Notable publications include 'Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK', 'Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE', and 'Implementation of mechanism of action biology-driven early drug development for children with cancer'.
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
Family Members Dealing With Childhood Cancer: A Study on the Role of Family Functioning and Cancer Appraisal
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
Family Adjustment When Facing Pediatric Cancer: The Role of Parental Psychological Flexibility, Dyadic Coping, and Network Support
Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE
Implementation of mechanism of action biology-driven early drug development for children with cancer
Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK